Facet Wealth Inc’s Pfizer PFE Stock Holding History

Facet Wealth Inc’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$418K	Buy	14,884 +2,416	+19%	+$64.3K	0.01%	196
2025 Q4	$322K	Buy	+12,468	New	+$314K	0.01%	212

Other funds holding PFE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Facet Wealth Inc's PFE Position: Q1 2026 in Review

Facet Wealth Inc increased its Pfizer (PFE) stake by 19% in Q1 2026, buying an estimated $64.3K and bringing the position to 14,884 shares worth $418K. The position accounts for 0.01% of the portfolio, ranked #196.

Facet Wealth Inc first reported a position in PFE in Q4 2025 and has held it in 2 quarters since. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

Facet Wealth Inc held 14,884 shares of Pfizer worth $418K as of Q1 2026.
Facet Wealth Inc bought 2,416 Pfizer shares in Q1 2026, an estimated $64.3K.
Pfizer made up 0.01% of Facet Wealth Inc's portfolio in Q1 2026, its #196 holding.
Facet Wealth Inc first reported a position in Pfizer in Q4 2025 and has held it in 2 quarters since.
2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Facet Wealth Inc's 13F filing for Q1 2026, filed 7 May 2026.